Recently, Chung et al. 33 have demonstrated that interleukin-17 (IL-17) promotes tumour resistance to VEGF inhibition by mediating immature myeloid-cell mobilization and recruitment into the tumour microenvironment in mice. This evidence concerns the gene VEGFA and neoplasm.